At the time of writing, Medpace Holdings Inc [MEDP] stock is trading at $290.10, up 1.04%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The MEDP shares have lost -4.79% over the last week, with a monthly amount drifted -12.83%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Medpace Holdings Inc [NASDAQ: MEDP] stock has seen the most recent analyst activity on March 24, 2025, when Leerink Partners initiated its Market Perform rating and assigned the stock a price target of $330. Previously, Robert W. Baird downgraded its rating to Neutral on October 23, 2024, and dropped its price target to $349. On October 14, 2024, Redburn Atlantic initiated with a Buy rating. UBS downgraded its rating to a Neutral and decreased its price target to $350 on September 27, 2024. Jefferies downgraded its rating to a Hold and reduced its price target to $345 on September 25, 2024. Truist started tracking with a Hold rating for this stock on August 01, 2024, and assigned it a price target of $415. In a note dated May 29, 2024, TD Cowen initiated an Buy rating and provided a target price of $452 on this stock.
For the past year, the stock price of Medpace Holdings Inc fluctuated between $282.42 and $459.77. Currently, Wall Street analysts expect the stock to reach $339.5 within the next 12 months. Medpace Holdings Inc [NASDAQ: MEDP] shares were valued at $290.10 at the most recent close of the market. An investor can expect a potential return of 17.03% based on the average MEDP price forecast.
Analyzing the MEDP fundamentals
According to Medpace Holdings Inc [NASDAQ:MEDP], the company’s sales were 2.11B for trailing twelve months, which represents an 7.66% jump. Gross Profit Margin for this corporation currently stands at 0.31% with Operating Profit Margin at 0.21%, Pretax Profit Margin comes in at 0.23%, and Net Profit Margin reading is 0.19%. To continue investigating profitability, this company’s Return on Assets is posted at 0.19, Equity is 0.51 and Total Capital is 0.45. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.15.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 275.39 points at the first support level, and at 260.69 for the second support level. However, for the 1st resistance point, the stock is sitting at 303.43, and for the 2nd resistance point, it is at 316.77.
Ratios To Look Out For
It is important to note that Medpace Holdings Inc [NASDAQ:MEDP] has a current ratio of 0.93. Further, the Quick Ratio stands at 0.93, while the Cash Ratio is 0.61. Considering the valuation of this stock, the price to sales ratio is 4.16, the price to book ratio is 10.74 and price to earnings (TTM) ratio is 22.96.
Transactions by insiders
Recent insider trading involved EWALD STEPHEN P, General Counsel & Corp. Secy., that happened on Feb 27 ’25 when 2.0 shares were purchased. Director, Carley Brian T completed a deal on Feb 24 ’25 to sell 4003.0 shares. Meanwhile, Director Carley Brian T bought 4003.0 shares on Feb 24 ’25.
